Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10418486 | 0.78 | POLB (0.40) | NPSR1ALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL17674048 | 0.75 | DHFR (0.42) | — | |
| SCHEMBL28733031 | 0.75 | NPSR1 (0.32) | NPSR1ALDH1A1CYP2D6TDP1L3MBTL1 | |
| SCHEMBL398536 | 0.72 | NPSR1 (0.44) | NPSR1ALDH1A1TDP1L3MBTL1POLB | |
| SCHEMBL1792016 | 0.71 | ALDH1A1 (0.46) | NPSR1ALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL193916 | 0.71 | ALDH1A1 (0.46) | NPSR1ALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL4458935 | 0.71 | NPSR1 (0.47) | NPSR1ALDH1A1MAPTTDP1L3MBTL1 | |
| SCHEMBL1667246 | 0.71 | ALDH1A1 (0.38) | ALDH1A1POLB | |
| SCHEMBL11191178 | 0.71 | GOT1 (0.34) | — | |
| SCHEMBL17049294 | 0.71 | POLB (0.32) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100435027-C | Organic light receptor with charge transfer compound for electronic photographing | SAMSUNG ELECTRONICS CO LTD (KR) | 2008-11-19 | — | — | CN | disclosed |
| EP-1283448-B1 | Electrophotographic organophotoreceptors with charge transport compounds | SAMSUNG ELECTRONICS CO LTD (KR) | 2008-11-05 | — | — | EP | disclosed |
| US-7358014-B2 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-15 | — | — | US | disclosed |
| US-20050112490-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG ELECTRONICS CO., LTD. | 2005-05-26 | — | — | US | disclosed |
| US-20030113132-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG INFORMATION SYSTEMS AMERICA | 2003-06-19 | — | — | US | disclosed |
| CN-1410834-A | Organic light receptor with charge transfer compound for electronic photographing | SAMSUNG ELECTRONICS CO LTD (KR) | 2003-04-16 | — | — | CN | disclosed |
| EP-1283448-A2 | Electrophotographic organophotoreceptors with charge transport compounds | Samsung Electronics Co., Ltd. (KR) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113132-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SLC43A1, SLC18A2, SLC1A1 | NPSR1 240/4885ALDH1A1 1216/4885KDM4E 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.